NCT00121966View on ClinicalTrials.gov

South Danish Diabetes Study: Evaluation of the Antidiabetic Treatment of Type 2 Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Insulin Aspart

DRUG

Insulin NPH

DRUG

Metformin

DRUG

Rosiglitazone

Trial Locations (1)

5000

Diabetes Research Center, Odense

All Listed Sponsors
lead

Odense University Hospital

OTHER

NCT00121966 - South Danish Diabetes Study: Evaluation of the Antidiabetic Treatment of Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter